OPXA : Summary for Opexa Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 20 mins

Opexa Therapeutics, Inc. (OPXA)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.92-0.03 (-3.16%)
As of 2:33 PM EST. Market open.
People also watch:
CYTXPSTICUROSIRKOOL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.95
Open0.95
Bid0.92 x 1600
Ask0.95 x 6800
Day's Range0.88 - 0.99
52 Week Range0.50 - 4.93
Volume366,969
Avg. Volume820,287
Market Cap6.57M
Beta1.77
PE Ratio (TTM)-0.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to Opexa Therapeutics, Inc. : December 1, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Opexa Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OPXA-US. Comparing the performance and risk of Opexa Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube19 days ago

    ETFs with exposure to Opexa Therapeutics, Inc. : November 18, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Opexa Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OPXA-US. Comparing the performance and risk of Opexa Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
    Capital Cube22 days ago

    Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016

    Categories: Yahoo Finance Get free summary analysis Opexa Therapeutics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Opexa Therapeutics, Inc. – Synthetic Biologics, Inc., Biogen Inc., Fortress Biotech, Inc., Momenta Pharmaceuticals, Inc., Novartis AG Sponsored ADR and StemCells, Inc. (SYN-US, BIIB-US, FBIO-US, MNTA-US, NVS-US and ... Read more (Read more...)